Article
Upfront thoracic radiotherapy to primary lesion improves outcomes in patients with stage IV non-small cell lung cancer harboring EGFR mutations.
Journal of B.U.ON. : official journal of the Balkan Union of Oncology - 1 Jan 2000
Kotek Sedef Ayse, Akkus Yildirim Berna, Topkan Erkan, Taner Sumbul Ahmet
Abstract excerpt
PURPOSE: The role of thoracic radiotherapy in the treatment of metastatic EGFR mutant non-small cell lung cancer (NSCLC) patients in literature data are insufficient.The purpose of this study was to examine the effectiveness of upfront thoracic radiotherapy in metastatic EGFR mutant NSCLC patients treated with chemotherapy or tyrosine kinase inhibitors (TKI). METHODS: This study was designed as a hospital-based...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
